FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35035511000001109: Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Feb 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106265001000001112 Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106265101000001113 Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Is a Canakinumab 150mg/1ml solution for injection vials true Inferred relationship Existential restriction modifier
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient Canakinumab true Inferred relationship Existential restriction modifier
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Canakinumab true Inferred relationship Existential restriction modifier
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Is a Ilaris true Inferred relationship Existential restriction modifier
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has AMP True Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start